ANXA6 and Alzheimer disease: Finally, we demonstrate that, as in other systems (muscle, heart, and primary neurons), exogenous recombinant annexin A6 can localize to and bind damaged neuronal membranes from the extracellular space, opening the possibility for a protein-based AD therapy.